Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Plasma retinol: a novel marker for cardiovascular disease mortality in Australian adults.

Brazionis L, Walker KZ, Itsiopoulos C, O'Dea K.

Nutr Metab Cardiovasc Dis. 2012 Oct;22(10):914-20. doi: 10.1016/j.numecd.2011.08.009. Epub 2011 Nov 26.

PMID:
22119336
2.

Does a Mediterranean diet reduce the mortality risk associated with diabetes: evidence from the Melbourne Collaborative Cohort Study.

Hodge AM, English DR, Itsiopoulos C, O'Dea K, Giles GG.

Nutr Metab Cardiovasc Dis. 2011 Sep;21(9):733-9. doi: 10.1016/j.numecd.2010.10.014. Epub 2010 Dec 30.

PMID:
21194913
3.

Dietary vitamin A may be a cardiovascular risk factor in a Saudi population.

Alissa EM, Bahjri SM, Al-Ama N, Ahmed WH, Starkey B, Ferns GA.

Asia Pac J Clin Nutr. 2005;14(2):137-44.

4.

Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease.

Taylor LM Jr, Moneta GL, Sexton GJ, Schuff RA, Porter JM.

J Vasc Surg. 1999 Jan;29(1):8-19; discussion 19-21.

5.

Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events.

Albert MA, Glynn RJ, Buring J, Ridker PM.

Circulation. 2006 Dec 12;114(24):2619-26. Epub 2006 Nov 20.

6.

New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).

Eeg-Olofsson K, Cederholm J, Nilsson PM, Zethelius B, Svensson AM, Gudbjörnsdóttir S, Eliasson B.

J Intern Med. 2010 Nov;268(5):471-82. doi: 10.1111/j.1365-2796.2010.02265.x.

7.

Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).

Barr EL, Zimmet PZ, Welborn TA, Jolley D, Magliano DJ, Dunstan DW, Cameron AJ, Dwyer T, Taylor HR, Tonkin AM, Wong TY, McNeil J, Shaw JE.

Circulation. 2007 Jul 10;116(2):151-7. Epub 2007 Jun 18.

8.

Elevated fasting total plasma homocysteine levels and cardiovascular disease outcomes in maintenance dialysis patients. A prospective study.

Bostom AG, Shemin D, Verhoef P, Nadeau MR, Jacques PF, Selhub J, Dworkin L, Rosenberg IH.

Arterioscler Thromb Vasc Biol. 1997 Nov;17(11):2554-8.

9.

C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.

Jeppesen J, Hansen TW, Olsen MH, Rasmussen S, Ibsen H, Torp-Pedersen C, Hildebrandt PR, Madsbad S.

Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):594-8. doi: 10.1097/HJR.0b013e328308bb8b.

PMID:
18753952
11.

Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.

Tanasescu M, Leitzmann MF, Rimm EB, Hu FB.

Circulation. 2003 May 20;107(19):2435-9. Epub 2003 Apr 28.

12.
13.

Brain natriuretic peptide between traditional and nontraditional risk factors in hemodialysis patients: analysis of cardiovascular mortality in a two-year follow-up.

Selim G, Stojceva-Taneva O, Spasovski G, Georgievska-Ismail L, Zafirovska-Ivanovska B, Gelev S, Dzekova P, Trajcevska L, Trojacanec-Piponska S, Sikole A.

Nephron Clin Pract. 2011;119(2):c162-70. doi: 10.1159/000327615. Epub 2011 Jul 8.

PMID:
21757955
14.

Plasma parathyroid hormone and the risk of cardiovascular mortality in the community.

Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J.

Circulation. 2009 Jun 2;119(21):2765-71. doi: 10.1161/CIRCULATIONAHA.108.808733. Epub 2009 May 18.

15.

Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.

Lee DS, Evans JC, Robins SJ, Wilson PW, Albano I, Fox CS, Wang TJ, Benjamin EJ, D'Agostino RB, Vasan RS.

Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):127-33. Epub 2006 Nov 9.

16.

Dietary patterns and cardiovascular mortality in the Melbourne Collaborative Cohort Study.

Harriss LR, English DR, Powles J, Giles GG, Tonkin AM, Hodge AM, Brazionis L, O'Dea K.

Am J Clin Nutr. 2007 Jul;86(1):221-9.

17.

A prospective study of uric acid by glucose tolerance status and survival: the Rancho Bernardo Study.

Kramer CK, von Mühlen D, Jassal SK, Barrett-Connor E.

J Intern Med. 2010 Jun;267(6):561-6. doi: 10.1111/j.1365-2796.2010.02168.x. Epub 2010 Mar 23.

18.

HbA1c is an independent predictor of non-fatal cardiovascular disease in a Caucasian population without diabetes: a 10-year follow-up of the Hoorn Study.

van 't Riet E, Rijkelijkhuizen JM, Alssema M, Nijpels G, Stehouwer CD, Heine RJ, Dekker JM.

Eur J Prev Cardiol. 2012 Feb;19(1):23-31. doi: 10.1097/HJR.0b013e32833b0932. Epub 2011 Jan 28.

PMID:
20517157
19.

Plasma lycopene, other carotenoids, and retinol and the risk of cardiovascular disease in women.

Sesso HD, Buring JE, Norkus EP, Gaziano JM.

Am J Clin Nutr. 2004 Jan;79(1):47-53.

20.

Fasting plasma leptin, tumor necrosis factor-alpha receptor 2, and monocyte chemoattracting protein 1 concentration in a population of glucose-tolerant and glucose-intolerant women: impact on cardiovascular mortality.

Piemonti L, Calori G, Mercalli A, Lattuada G, Monti P, Garancini MP, Costantino F, Ruotolo G, Luzi L, Perseghin G.

Diabetes Care. 2003 Oct;26(10):2883-9.

PMID:
14514596

Supplemental Content

Support Center